Location of Repository

Excitotoxic ATP and Glutamate Signalling during Central Nervous System Ischaemia

By Philipp Julio Vermehren


Neural cell death plays a crucial role in the pathogenesis of various ischaemic disorders of the central nervous system (CNS), most prominently stroke, causing very significant mortality and morbidity. Severe ischaemia rapidly kills both neurons and astrocytes, two CNS cell types whose interactions are essential to normal brain functioning, so ideally a target needs to be found which will protect both. Glutamate mediated excitotoxicity, the process whereby excessive extracellular glutamate causes cell death via the over-activation of ionotropic glutamate receptors, is known to operate during ischaemia.\ud However, there is increasing evidence that ATP mediated excitotoxicity may also occur. Using an in vitro model of ischaemia (oxygen-glucose deprivation: OGD) and various murine primary cortical cell cultures, I investigated the hypothesis that parallel pathways of ATP and glutamate mediated excitotoxicity contribute to the death of both astrocytes and neurons during ischaemia. OGD produced rapid and significant ATP and glutamate release from co-cultures of astrocytes and neurons, as measured using microelectrode biosensors. Glutamate release was mainly from astrocytes, whereas the cellular origin of ATP was less clear. Ca2+ imaging of Fura-2 loaded cells confirmed functional P2 receptor expression in all astrocytes and 60% of neurons along with glutamate receptor expression in all neurons but only a small proportion of astrocytes. During OGD, blocking NMDA and AMPA/kainate receptors significantly reduced neuronal death, while non-selective P2 receptor antagonists as well as selective P2Y1 (but not P2X7) receptor antagonists prevented the death of both neurons and astrocytes. Furthermore, a synergistic protective effect was produced by combining low concentrations of P2 and glutamate receptor antagonists, reducing cell death to control levels. These results suggest that ATP and glutamate, acting at P2 and ionotropic glutamate receptors, are the main mediators of early cell death during severe CNS ischaemia, and thus represent a potential target for powerful neuroprotective strategies

Publisher: University of Leicester
Year: 2010
OAI identifier: oai:lra.le.ac.uk:2381/8851

Suggested articles



  1. (1993). (1S, 3R)-ACPD protects synaptic transmission from hypoxia in hippocampal slices.
  2. (2001a) Calcium dependence of rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts.
  3. (2001b) Rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts.
  4. (2006a) Purinergic signalling--an overview. Novartis Found Symp 276:26-48; discussion 48-57,
  5. (2006b) Historical review: ATP as a neurotransmitter.
  6. (2006). (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
  7. (1998). (S)-4C3HPG reduces infarct size after focal cerebral ischemia.
  8. (2006). 1,026 experimental treatments in acute stroke.
  9. (1989). 2',3'-cyclic nucleotide 3'-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system.
  10. (2009). A
  11. (2006). A brief look at glial cells. Novartis Found Symp 276:5-14; discussion
  12. (2008). A central role of connexin 43 in hypoxic preconditioning.
  13. (2009). A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice.
  14. (2009). A microelectrode biosensor for real time monitoring of L-glutamate release.
  15. (1994). A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP.
  16. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties.
  17. (1995). A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
  18. (2005). A novel recombinant plasma membranetargeted luciferase reveals a new pathway for ATP secretion.
  19. (2006). A role for P2X7 in microglial proliferation.
  20. (1999). A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors.
  21. (2003). A transgenic mouse model for the detailed morphological study of astrocytes.
  22. (1999). A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.
  23. (2004). Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes.
  24. (1991). Activation of the metabotropic glutamate receptor attenuates Nmethyl-D-aspartate neurotoxicity in cortical cultures.
  25. (2004). Acute ischemic injury of astrocytes is mediated by Na-K-Cl cotransport and not Ca2+ influx at a key point in white matter development.
  26. (1997). Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus.
  27. (1999). Adenosine 5' triphosphate evoked mobilization of intracellular calcium in central nervous system white matter of adult mouse optic nerve.
  28. (1993). Adenosine 5'-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex.
  29. (2008). Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage.
  30. (2001). Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis.
  31. (2002). Adenosine triphosphate accelerates recovery from hypoxic/hypoglycemic perturbation of guinea pig hippocampal neurotransmission via a P(2) receptor.
  32. (2004). Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
  33. (2007). Adenosine, an endogenous distress signal, modulates tissue damage and repair.
  34. (2003). Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice.
  35. (2004). Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
  36. (2000). Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.
  37. (2001). Altered cytokine production in mice lacking P2X(7) receptors.
  38. (2006). Altered hippocampal synaptic potentiation in P2X4 knock-out mice.
  39. (1993). AMPA glutamate receptor subunits are differentially distributed in rat brain.
  40. (2004). AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression.
  41. (1996). AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked.
  42. (1999). AMPA receptor protein expression and function in astrocytes cultured from hippocampus.
  43. (2002). AMPA-induced Ca(2+) influx in cultured rat cortical nonpyramidal neurones: pharmacological characterization using fura-2 microfluorimetry.
  44. (2001). Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.
  45. (1996). An extracellular signaling component in propagation of astrocytic calcium waves.
  46. (1998). An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat.
  47. (1995). An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death.
  48. (1999). Anoxia-evoked intracellular pH and Ca2+ concentration changes in cultured postnatal rat hippocampal neurons.
  49. (1997). Anoxia-induced neuronal injury: role of Na+ entry and Na+-dependent transport.
  50. (1991). Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose.
  51. (2001). Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain.
  52. (2000). Apparent species differences in the kinetic properties of P2X(7) receptors.
  53. (1984). Aspartate, glutamate and gamma-aminobutyric acid depolarize cultured astrocytes.
  54. (1997). Astrocyte energetics, function, and death under conditions of incomplete ischemia: a mechanism of glial death in the penumbra.
  55. (2000). Astrocyte glutamate transport: review of properties, regulation, and physiological functions.
  56. (2007). Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmet hyl)propyl]-1H-indole-2-carboxamide).
  57. (2007). Astrocyte metabolism and signaling during brain ischemia.
  58. (2004). Astrocyte mitochondria in in vitro models of ischemia.
  59. (1992). Astrocyte precursors in neonatal rat spinal cord cultures.
  60. (2005). Astrocyte-neurone communication following oxygen-glucose deprivation.
  61. (2008). Astrocytes affect the profile of purines released from cultured cortical neurons.
  62. (2003). Astrocytes and brain injury.
  63. (2005). Astrocytes and ependymal glia. In: Neuroglia, 2nd edition Edition (Kettenmann H, Ransom B, eds), pp 19-35. Oxford:
  64. (2009). Astrocytes and ischemic injury.
  65. (2001). Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors.
  66. (1998). Astrocytes protect neurons from neurotoxic injury by serum glutamate.
  67. (2001). Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism.
  68. (2001). Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity.
  69. (2005). Astrocytes, from brain glue to communication elements: the revolution continues.
  70. (2009). Astrocytes: biology and pathology.
  71. (1999). Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain.
  72. (2003). Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia.
  73. (1997). Astrocytic neurotransmitter receptors in situ and in vivo.
  74. (2005). Astrocytic purinergic signaling coordinates synaptic networks.
  75. (2005). Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy.
  76. (2005). ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
  77. (2000). ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices.
  78. (2003). ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity.
  79. (2001). ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSCs in dorsal horn neurons of the rat spinal cord.
  80. (2002). ATP potently modulates anion channel-mediated excitatory amino acid release from cultured astrocytes.
  81. (1992). ATP receptor-mediated synaptic currents in the central nervous system.
  82. (2008). ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in vitro.
  83. (2005). ATP release during ischemia as a harbinger of cell death?
  84. (2009). ATP release from non-excitable cells. Purinergic Signal.
  85. (2003). ATP released from astrocytes during swelling activates chloride channels.
  86. (2001). ATP stimulates calcium-dependent glutamate release from cultured astrocytes.
  87. (2004). ATP- and adenosine-mediated signaling in the central nervous system: adenosine stimulates glutamate release from astrocytes via A2a adenosine receptors.
  88. (2009). ATP-gated P2X cation-channels.
  89. (2009). ATP-gated P2X receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous glutamate release.
  90. (2002). ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
  91. (2003). ATP-induced, sustained calcium signalling in cultured rat cortical astrocytes: evidence for a non-capacitative, P2X7-like-mediated calcium entry.
  92. (1997). ATP-mediated cytotoxicity in microglial cells.
  93. (2000). ATP-mediated glia signaling.
  94. (2007). Auto-inhibition of rat parallel fibre-Purkinje cell synapses by activity-dependent adenosine release.
  95. (2000). Baskys A
  96. (1999). Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
  97. (2008). Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke.
  98. (1996). Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system.
  99. (2008). Bioenergetics of cerebral ischemia: a cellular perspective.
  100. (1987). Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes.
  101. (1995). Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro.
  102. (2003). Blockade of ionotropic glutamate receptors produces neuronal apoptosis through the Bax-cytochrome C-caspase pathway: the causative role of Ca2+ deficiency.
  103. (1991). Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.
  104. Boarder MR (1996b) PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
  105. (1991). Both NMDA and non-NMDA subtypes of glutamate receptors are concentrated at synapses on cerebral cortical neurons in culture.
  106. (2009). Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.
  107. (1988). Brain ion homeostasis in cerebral ischemia.
  108. (1969). Brain lesions in an infant rhesus monkey treated with monsodium glutamate.
  109. (1969). Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.
  110. (2007). Ca2+ signals and neuronal death in brain ischemia.
  111. (2004). Calcium and pH homeostasis in neurons during hypoxia and ischemia.
  112. (1989). Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis.
  113. (1990). Calcium in the brain under physiological and pathological conditions.
  114. (2003). Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors.
  115. (1995). Calcium: still center-stage in hypoxic-ischemic neuronal death.
  116. Carmignoto G (2006a) Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes.
  117. (2007). Case report: An unusual complication of clopidogrel.
  118. (2009). Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking.
  119. (1993). Cellpermeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo.
  120. (2004). Cellular distribution and functions of P2 receptor subtypes in different systems.
  121. (1994). Cellular localization and laminar distribution of AMPA glutamate receptor subunits mRNAs and proteins in the rat cerebral cortex.
  122. (1996). Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity.
  123. (1998). Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor.
  124. (2001). Cerebral white matter damage in the preterm infant: pathophysiology and risk factors.
  125. (2003). Cerebral white matter injury of the premature infant-more common than you think.
  126. (1996). Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex.
  127. (1986). Changes in levels of purine and pyrimidine nucleotides during acute hypoxia and recovery in neonatal rat brain.
  128. (2005). Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death.
  129. (1990). Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents.
  130. (1988). Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes.
  131. (2009). Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.
  132. (2002). Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
  133. (2007). Characterization of functional P2X(1) receptors in mouse megakaryocytes.
  134. (1997). Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue.
  135. (1997). Characterization of the Ca2+ responses evoked by ATP and other nucleotides in mammalian brain astrocytes.
  136. (2008). Chemical calcium indicators.
  137. (1996). Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.
  138. (1998). Cloning and functional characterisation of the mouse P2X7 receptor.
  139. (2001). Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder.
  140. (1996). Cloning, functional expression and tissue distribution of the human P2Y6 receptor.
  141. (2005). Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity.
  142. (1998). Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
  143. (2007). Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus.
  144. (2000). Coexpression of several types of metabotropic nucleotide receptors in single cerebellar astrocytes.
  145. (1993). Combined oxygen and glucose deprivation in cortical cell culture: calciumdependent and calcium-independent mechanisms of neuronal injury.
  146. (1991). Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.
  147. (1998). Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate.
  148. (1994). Complex correlation between excitatory amino acid-induced increase in the intracellular Ca2+ concentration and subsequent loss of neuronal function in individual neocortical neurons in culture.
  149. (2008). Connexin 43 hemichannels are permeable to ATP.
  150. (2000). Connexin43 phosphorylation state and intercellular communication in cultured astrocytes following hypoxia and protein phosphatase inhibition.
  151. (1998). Connexins regulate calcium signaling by controlling ATP release.
  152. (2004). Contribution of calcium ions to P2X channel responses.
  153. (2008). Contribution of P2Y(1) receptors to ADP signalling in mouse spinal cord cultures.
  154. (2001). Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity.
  155. (2007). Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance.
  156. (2002). Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor.
  157. (2001). Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate.
  158. (1991). Cytosolic free Ca2+ and proteolysis in lethal oxidative injury in endothelial cells.
  159. (1971). Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system.
  160. De Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke.
  161. (1999). Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.
  162. (2002). Delayed anoxic depolarizations in hippocampal neurons of mice lacking the excitatory amino acid carrier 1.
  163. (1994). Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke 25:457-464; discussion
  164. (2009). Development of selective agonists and antagonists of P2Y receptors.
  165. (1998). Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons.
  166. (1998). Developmental changes in purinergic calcium signalling in rat neocortical neurones.
  167. (2001). Developmental expression of metabotropic P2Y(1) and P2Y(2) receptors in freshly isolated astrocytes from rat hippocampus.
  168. (1996). Developmental regulation of the toxin sensitivity of Ca(2+)-permeable AMPA receptors in cortical glia.
  169. (2000). Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons.
  170. (2002). Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions.
  171. (2001). Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival.
  172. (2005). Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons.
  173. (2009). Different properties of P2X(7) receptor in hippocampal and cortical astrocytes.
  174. (1998). Differential effects of anoxia and glutamate on cultured neocortical neurons.
  175. (2003). Differential frequency dependence of P2Y1- and P2Y2-mediated Ca 2+ signaling in astrocytes.
  176. (1991). Differential intracellular calcium responses to glutamate in type 1 and type 2 cultured brain astrocytes.
  177. (1999). Differential sensitivity of cultured tanycytes and astrocytes to hydrogen peroxide toxicity.
  178. (2001). Differential sensitivity of murine astrocytes and neurons from different brain regions to injury.
  179. (2000). Differential sensitivity of rat hippocampal and cortical astrocytes to oxygenglucose deprivation injury.
  180. (1977). Direct detection of depolarisation-induced release of ATP from a synaptosomal preparation.
  181. (2000). Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice.
  182. (1998). Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity.
  183. (2001). Distinct Localization of P2X receptors at excitatory postsynaptic specializations.
  184. (2003). Distinct roles of P2X receptors in modulating glutamate release at different primary sensory synapses in rat spinal cord.
  185. (1996). distribution and properties of an extended family of ATP-gated ion channels.
  186. (1997). Distribution of [35S]dATP alpha S binding sites in the adult rat neuraxis.
  187. (2001). Distribution of P2X receptors on astrocytes in juvenile rat hippocampus.
  188. (2004). Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
  189. (2005). Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
  190. (1999). Ducati A
  191. (2003). Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures.
  192. (2008). Ectodomain lysines and suramin block of P2X1 receptors.
  193. (2006). Ectonucleotidases in the nervous system. Novartis Found Symp 276:113-128; discussion 128-130,
  194. (1988). Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
  195. (2000). Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons.
  196. (1995). Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus.
  197. (1997). Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke.
  198. (1999). Effects of astrocytes on neuronal attachment and survival shown in a serumfree co-culture system.
  199. (2002). Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia.
  200. (2008). Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell linederived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways.
  201. (1998). Effects of the P2-purinoceptor antagonists suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid on glutamatergic synaptic transmission in rat dorsal horn neurons of the spinal cord.
  202. (1992). Efflux of glutamate produced by short ischemia of varied severity in rat striatum.
  203. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis.
  204. (2002). Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
  205. (1999). Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels.
  206. (2001). Endothelin-1 protects astrocytes from hypoxic/ischemic injury.
  207. (2001). Enhanced spontaneous transmitter release is the earliest consequence of neocortical hypoxia that can explain the disruption of normal circuit function.
  208. (2004). Evaluation of the child with cerebral palsy.
  209. (1996). Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization.
  210. (2007). Evidence for functional P2X4/P2X7 heteromeric receptors.
  211. (2004). Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia.
  212. (1997). Evidence that the early loss of membrane protein kinase C is a necessary step in the excitatory amino acid-induced death of primary cortical neurons.
  213. (2006). Evolving therapeutic approaches to treating acute ischemic stroke.
  214. (1995). Excitatory amino acid release from astrocytes during energy failure by reversal of sodium-dependent uptake.
  215. (1984). Excitatory amino acids directly depolarize rat brain astrocytes in primary culture.
  216. (2002). Excitotoxicity in glial cells.
  217. (2007). Exocytotic release of ATP from cultured astrocytes.
  218. (2009). Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord.
  219. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells.
  220. (1996). Expression of NR1 and NR2A/B subunits of the NMDA receptor in cortical astrocytes.
  221. (2009). Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia.
  222. (2005). Expression of reef coral fluorescent proteins in the central nervous system of transgenic mice.
  223. (2003). Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.
  224. (2002). Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors.
  225. (2002). Extracellular ATP and P2X7 receptors in neurodegeneration.
  226. (1998). Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors.
  227. (1994). Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures.
  228. (1992). Extracellular calcium is a mediator of astroglial injury during combined glucose-oxygen deprivation.
  229. (2001). Extracellular nucleotides regulate cellular functions of podocytes in culture.
  230. (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.
  231. (2005). Failure and function of intracellular pH regulation in acute hypoxic-ischemic injury of astrocytes.
  232. (1990). Fluorescence measurement of changes in intracellular calcium induced by excitatory amino acids in cultured cortical astrocytes.
  233. (1990). Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
  234. (2003). Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1.
  235. (2000). Functional characterization of the P2X(4) receptor orthologues.
  236. (2006). Functional connexin "hemichannels": a critical appraisal.
  237. (2004). Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae.
  238. (2000). Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.
  239. (2003). Functional hemichannels in astrocytes: a novel mechanism of glutamate release.
  240. (2000). Functional properties of heteromeric P2X(1/5) receptors expressed in HEK cells and excitatory junction potentials in guineapig submucosal arterioles.
  241. (1998). Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization.
  242. (1998). Functional studies in cultured astrocytes.
  243. Gean PW (2008a) Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons.
  244. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA.
  245. (2001). GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.
  246. (1995). GFAP-positive hippocampal astrocytes in situ respond to glutamatergic neuroligands with increases in
  247. (2007). GFP imaging of live astrocytes: regional differences in the effects of ischaemia upon astrocytes.
  248. (2008). Glia get excited.
  249. (1998). Glia modulate NMDA-mediated signaling in primary cultures of cerebellar granule cells.
  250. (1995). Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity.
  251. (2003). Glial cells and neurotransmission: an inclusive view of synaptic function.
  252. (1995). Glial cells in the mouse hippocampus express AMPA receptors with an intermediate Ca2+ permeability.
  253. (1999). Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis.
  254. (2000). Glial fibrillary acidic protein: GFAP-thirty-one years
  255. (1993). Glial glycogen stores affect neuronal survival during glucose deprivation in vitro.
  256. (1991). Glial ion channels.
  257. (2004). Glial modulation of synaptic transmission in culture.
  258. (2004). Glial perspectives of metabolic states during cerebral hypoxia--calcium regulation and metabolic energy.
  259. (1989). Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus.
  260. (2000). Gliotoxic action of glutamate on cultured astrocytes.
  261. (1989). Glucose deprivation neuronal injury in cortical culture.
  262. (2006). Glutamate acts at NMDA receptors on fresh bovine and on cultured human retinal pigment epithelial cells to trigger release of ATP.
  263. (2006). Glutamate and GABA metabolism in transient and permanent middle cerebral artery occlusion in rat: importance of astrocytes for neuronal survival.
  264. (1995). Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures.
  265. (2004). Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.
  266. (2006). Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport.
  267. (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent.
  268. (1987). Glutamate neurotoxicity in cortical cell culture.
  269. (1994). Glutamate receptor agonists stimulate diverse calcium responses in different types of cultured rat cortical glial cells.
  270. (2001). Glutamate receptor subunit expression in primary neuronal and secondary glial cultures.
  271. (1989). Glutamate receptor-linked changes in membrane potential and intracellular Ca2+ in primary rat astrocytes.
  272. (1990). Glutamate receptors activate Ca2+ mobilization and Ca2+ influx into astrocytes.
  273. (1998). Glutamate receptors in the mammalian central nervous system.
  274. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake.
  275. (1985). Glutamate stimulates inositol phosphate formation in striatal neurones.
  276. (2003). Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents.
  277. (1992). Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture.
  278. (2001). Glutamate uptake.
  279. (1998). Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice.
  280. (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.
  281. (2006). Glutamate-mediated glial injury: mechanisms and clinical importance.
  282. (2005). Glutamate-mediated influx of extracellular Ca2+ is coupled with reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes.
  283. (2009). Glutamatergic signaling in the brain's white matter.
  284. (2008). Guide to Receptors and Channels (GRAC), 3rd edition.
  285. (1985). Hamberger A
  286. (2002). High sensitivity of protoplasmic cortical astroglia to focal ischemia.
  287. (2003). High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices.
  288. (1988). Historical overview. Calcium, ischemia, and death of brain cells.
  289. (1998). Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
  290. (1989). Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex.
  291. (2008). Hyperoxia promotes astrocyte cell death after oxygen and glucose deprivation.
  292. (2000). Hypothermia inhibits ischemia-induced efflux of amino acids and neuronal damage in the hippocampus of aged rats.
  293. (2007). Hypoxia suppresses glutamate transport in astrocytes.
  294. (1989). Hypoxia-induced dysfunctions and injury of astrocytes in primary cell cultures.
  295. (1997). Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum.
  296. (2005). Identification and characterization of splice variants of the human P2X7 ATP channel.
  297. (2000). Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes.
  298. (1998). Immunorecognition, ultrastructure and phosphorylation status of astrocytic gap junctions and connexin43 in rat brain after cerebral focal ischaemia.
  299. (2008). Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells.
  300. (2009). Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration.
  301. (1996). In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes.
  302. (2004). In, out, shake it all about: elevation of [Ca2+]i during acute cerebral ischaemia.
  303. (2009). Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
  304. (2003). Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus.
  305. (2004). Increased release of excitatory amino acids by the actions of ATP and peroxynitrite on volume-regulated anion channels (VRACs) in astrocytes.
  306. (1998). Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses.
  307. (2004). Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
  308. (1997). Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study.
  309. (2003). Influence of serum-free medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons.
  310. (1995). Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons.
  311. (1995). Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
  312. (2002). Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice.
  313. (2004). Inhibition of glutamate-induced delayed calcium deregulation by 2-APB and La3+ in cultured cortical neurones.
  314. (1999). Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker.
  315. (1998). Inhibition of NMDA-gated ion channels by the P2 purinoceptor antagonists suramin and reactive blue 2 in mouse hippocampal neurones.
  316. (2001). Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
  317. (1992). Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses.
  318. (1996). Inhibition of receptor/G protein coupling by suramin analogues.
  319. (2004). Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection.
  320. (1963). Inhibition of the Smooth Muscle on the Taenia Coli.
  321. (1964). Innervation of the Guinea-Pig Taenia Coli: Are There Intrinsic Inhibitory Nerves Which Are Distinct from Sympathetic Nerves?
  322. (2002). Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex.
  323. (2002). Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels.
  324. (2002). Intercellular calcium signaling mediated by point-source burst release of ATP.
  325. (2006). Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release.
  326. (1998). Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ.
  327. (2005). Intracellular calcium and cell death in neonatal rat white matter astrocytes and neurons during ischaemia: protective effects of suramin and glutamate receptor blockers and the importance of astrocyte neuronal interactions. In:
  328. (1991). Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury.
  329. (1990). Intracellular free calcium increases in cultured cortical neurons deprived of oxygen and glucose.
  330. (1999). Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices.
  331. (2006). Involvement of P2 receptors in the growth and survival of neurons in the CNS.
  332. (2002). Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus.
  333. (1997). Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells.
  334. (2000). Ionic selectivity of low-affinity ratiometric calcium indicators:
  335. (1998). Iono- and metabotropically induced purinergic calcium signalling in rat neocortical neurons.
  336. (2005). Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl)
  337. (2001). Ionotropic glutamate receptors in astrocytes.
  338. (1985). Is there a basis for distinguishing two types of P2-purinoceptor?
  339. (2001). Ischemia-induced apoptosis in primary cultures of astrocytes.
  340. (1993). Ischemia-induced death of astrocytes and neurons in primary culture: pitfalls in quantifying neuronal cell death.
  341. (1999). Ischemia-induced glutamate release in the dentate gyrus. A microdialysis study in the gerbil.
  342. (2001). Ischemia: astrocytes show their sensitive side.
  343. (1999). Ischemic cell death in brain neurons.
  344. (1996). Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analyses.
  345. (2008). Ischemic stroke and neurogenesis in the subventricular zone.
  346. (1998). Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
  347. (2007). Ivermectin potentiates ATP-induced ion currents in cortical neurones: evidence for functional expression of P2X4 receptors?
  348. (1994). Kainate activates Ca(2+)-permeable glutamate receptors and blocks voltage-gated K+ currents in glial cells of mouse hippocampal slices.
  349. (2006). Kainate receptors.
  350. Kawahara K (2009a) Oxygen-glucose deprivation-induced enhancement of extracellular ATPP2Y purinoceptors signaling for the propagation of astrocytic calcium waves.
  351. Kawahara K (2009b) Possible involvement of extracellular ATP-P2Y purinoceptor signaling in ischemia-induced tolerance of astrocytes in culture.
  352. (2002). Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia.
  353. (1995). Kowalczyk A
  354. (2004). Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice.
  355. (1992). Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain.
  356. (2005). Listening to the brain: microelectrode biosensors for neurochemicals.
  357. (2006). Localization of glutamate receptors in developing cortical neurons in culture and relationship to susceptibility to excitotoxicity.
  358. (1997). Loss of ATP diphosphohydrolase activity with endothelial cell activation.
  359. (1991). Lyons and Kettenmann,
  360. (2007). Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts.
  361. (2008). Magnetic resonance imaging in cerebral ischemia: focus on neonates.
  362. (1993). Major differences in Ca2+i response to anoxia between neonatal and adult rat CA1 neurons: role of Ca2+o and Na+o.
  363. (2009). Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.
  364. Maura G (2004a) 5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices.
  365. (2004). Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release.
  366. (2008). Mechanisms of glutamate release from astrocytes.
  367. (2002). Mechanisms of hypoxic neurodegeneration in the developing brain.
  368. (2008). Mechanisms of ischemic brain damage.
  369. (2008). Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra.
  370. (2005). Melani A
  371. (1997). Messing A
  372. (2003). Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
  373. (2002). Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture.
  374. (1990). Metabolism and role of glutamate in mammalian brain.
  375. (1997). Metabotropic glutamate receptor activation modulates kainate and serotonin calcium response in astrocytes.
  376. (2003). Metabotropic glutamate receptor regulation of neuronal cell death.
  377. (2008). Metabotropic Glutamate Receptors in Glial Cells. Neurochem Res.
  378. (2006). Metabotropic glutamate receptors.
  379. (2007). Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption.
  380. (2005). Microelectrode biosensor for real-time measurement of ATP in biological tissue.
  381. (2005). Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage.
  382. (2007). Microglial cells in astroglial cultures: a cautionary note.
  383. (1999). Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange.
  384. (2001). Molecular and biochemical mechanisms of perinatal brain injury.
  385. (1999). Molecular and functional characterization of human P2X(2) receptors.
  386. (1997). Molecular characterization and pharmacological properties of the human P2X3 purinoceptor.
  387. (2001). Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.
  388. (1995). Molecular cloning and functional analysis of a novel P2 nucleotide receptor.
  389. (2003). Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity.
  390. (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death.
  391. (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.
  392. (2004). Molecular physiology of P2 receptors in the central nervous system.
  393. (2002). Molecular physiology of P2X receptors.
  394. (2006). Molecular properties of P2X receptors.
  395. (2007). Morphological and physiological interactions of NG2-glia with astrocytes and neurons.
  396. (1983). Morphological classification of rat cortical neurons in cell culture.
  397. MR (2006a) Purine release from spinal cord microglia after elevation of calcium by glutamate.
  398. (1987). N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture.
  399. (2003). Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity.
  400. (2004). Na-K-Cl cotransporter-mediated intracellular Na+ accumulation affects Ca2+ signaling in astrocytes in an in vitro ischemic model.
  401. (2004). Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures.
  402. (1997). Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists.
  403. (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse.
  404. (2001). Neurobiology of periventricular leukomalacia in the premature infant.
  405. (1996). Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage.
  406. (1998). Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis.
  407. (2004). Neuroenergetics: calling upon astrocytes to satisfy hungry neurons.
  408. (1996). Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke.
  409. (2006). Neurogenesis in the caudate nucleus of the adult rabbit.
  410. (1994). Neuron-specific enolase.
  411. (1997). Neuronal and glial localization of NMDA receptors in the cerebral cortex.
  412. (2000). Neuronal death enhanced by N-methyl-D-aspartate antagonists.
  413. (2008). Neuronal injury induces the release of pro-interleukin1beta from activated microglia in vitro.
  414. (2004). Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors.
  415. (1997). Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia.
  416. (1998). Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta.
  417. (2008). Neuroprotection for ischemic stroke: past, present and future.
  418. (2004). Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
  419. (2006). Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia.
  420. (1999). Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
  421. (1998). Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
  422. (1994). Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids.
  423. (1994). Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
  424. (1993). Neuroprotective effects of glutamate antagonists and extracellular acidity.
  425. (1999). Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones.
  426. (2006). Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats.
  427. (2003). New roles for astrocytes: redefining the functional architecture of the brain.
  428. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
  429. (2002). Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes.
  430. (1996). Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med
  431. (2000). NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.
  432. (2008). NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.
  433. (2005). NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
  434. (2005). NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.
  435. (2007). NMDA Receptors in glia.
  436. (2006). NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
  437. (2001). NMDA-responsible, APV-insensitive receptor in cultured human astrocytes.
  438. (1990). Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake.
  439. (1999). Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport.
  440. (2007). Nucleotide receptor signalling and the generation of reactive oxygen species.
  441. (2003). Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
  442. (1999). Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice.
  443. (1998). Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro.
  444. (1998). Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity.
  445. (1994). Origin of ischemia-induced glutamate efflux in the CA1 field of the gerbil hippocampus: an in vivo brain microdialysis study.
  446. (1998). Origins of the extracellular glutamate released during total metabolic blockade in the immature retina.
  447. (2008). Oxygen-glucose deprivation induces ATP release via maxi-anion channels in astrocytes.
  448. (2000). P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes.
  449. (1997). P2 purinoceptor blocker suramin antagonises NMDA receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats.
  450. (1996). P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies.
  451. (2005). P2 receptor antagonist PPADS confers neuroprotection against glutamate/NMDA toxicity.
  452. (2007). P2 receptor antagonist trinitrophenyladenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death.
  453. (2002). P2 receptor modulation and cytotoxic function in cultured CNS neurons.
  454. (2006). P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions. Novartis Found Symp 276:131-143; discussion 143-137,
  455. (2004). P2 receptor-mediated effects on the open field behaviour of rats in comparison with behavioural responses induced by the stimulation of dopamine D2-like and by the blockade of ionotrophic glutamate receptors.
  456. (2001). P2 receptor-types involved in astrogliosis in vivo.
  457. (2006). P2 receptors and neuronal injury.
  458. (2001). P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ.
  459. (2007). P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.
  460. (2006). P2X(7) receptors on microglial cells mediate injury to cortical neurons in vitro.
  461. (2006). P2X(7) receptors: properties and relevance to CNS function.
  462. (2005). P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP.
  463. (1996). P2X4: an ATP-activated ionotropic receptor cloned from rat brain.
  464. (2003). P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease.
  465. (2004). P2X7 receptor expression after ischemia in the cerebral cortex of rats.
  466. (2004). P2X7 receptor inhibition improves recovery after spinal cord injury.
  467. (2006). P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat.
  468. (2003). P2X7 receptor-mediated release of excitatory amino acids from astrocytes.
  469. (2006). P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling.
  470. (2002). P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system.
  471. (2003). P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia.
  472. (2007). P2Y receptor-activating nucleotides modulate cellular reactive oxygen species production in dissociated hippocampal astrocytes and neurons in culture independent of parallel cytosolic Ca(2+) rise and change in mitochondrial potential.
  473. (2007). P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
  474. (2002). P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse.
  475. (2009). P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures.
  476. (2006). P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins.
  477. (2008). Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels.
  478. (2004). Pathogenesis of hippocampal neuronal death after hypoxia-ischemia changes during brain development.
  479. (2007). Pathologically activated therapeutics for neuroprotection.
  480. (2001). Pathways of neuron-astrocyte interactions and their possible role in neuroprotection.
  481. (1962). Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy.
  482. (1985). Pertussis toxin reverses adenosine inhibition of neuronal glutamate release.
  483. PG (2006b) Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found Symp 276:208-217; discussion 217-221,
  484. (2003). Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Muller cells.
  485. (1999). Pharmacological characterization of recombinant human and rat P2X receptor subtypes.
  486. (1999). Pharmacological characterization of the human P2Y11 receptor.
  487. (2003). Pharmacological characterization of the human P2Y13 receptor.
  488. (1996). Pharmacological characterization of the human P2Y4 receptor.
  489. (2006). Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in cultured rat astrocytes.
  490. (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
  491. (1985). Pharmacological properties of gamma-aminobutyric acid-, glutamate-, and aspartate-induced depolarizations in cultured astrocytes.
  492. (1988). Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists.
  493. (2006). Pharmacology of P2X channels.
  494. (1992). Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
  495. (1996). Postnatal retinal ganglion cells in vitro: protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes.
  496. (2003). Potentiation by ATP of lipopolysaccharide-stimulated nitric oxide production in cultured astrocytes.
  497. (1992). PPADS, a novel functionally selective antagonist of P2 purinoceptormediated responses.
  498. (1993). Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.
  499. (1995). Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists.
  500. (1999). Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C.
  501. (1997). Protective mechanisms of adenosine in neurons and glial cells.
  502. (2006). protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.
  503. Pulsinelli WA (1991a) The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats.
  504. (2007). Purine-mediated signalling triggers eye development.
  505. (2002). Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism.
  506. (2004). Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo.
  507. (2007). Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
  508. (1972). Purinergic nerves.
  509. (2003). Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices.
  510. (2008). Purinergic P2X receptors presynaptically increase glutamatergic synaptic transmission in dorsolateral periaqueductal gray.
  511. (1976). Purinergic receptors.
  512. (2006). Purinergic signalling in neuron-glia interactions.
  513. (2009). Purinergic signalling in the nervous system: an overview.
  514. (2001). Purinergic signalling: ATP release.
  515. (2008). Purinergic systems in microglia.
  516. (2009). Purinoceptors on neuroglia.
  517. (2007). Quantal release of ATP in mouse cortex.
  518. (1988). Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.
  519. (2004). Raising intracellular calcium attenuates neuronal apoptosis triggered by staurosporine or oxygen-glucose deprivation in the presence of glutamate receptor blockade.
  520. (2000). Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop.
  521. (1998). Receptors for purines and pyrimidines.
  522. (2000). Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors.
  523. (1992). Reggiani A
  524. (2000). Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: striking neuronal localisation.
  525. (2007). Regulated ATP release from astrocytes through lysosome exocytosis.
  526. (2008). Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells.
  527. (2006). Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.
  528. (2006). Regulation of intracellular Ca2+ by P2Y1 receptors may depend on the developmental stage of cultured rat striatal neurons.
  529. (2004). Regulation of neuronal ion channels via P2Y receptors.
  530. (1997). Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia.
  531. (2008). Release of ATP and glutamate in the nucleus tractus solitarii mediate pulmonary stretch receptor (Breuer-Hering) reflex pathway.
  532. (2007). Resolving vesicle fusion from lysis to monitor calcium-triggered lysosomal exocytosis in astrocytes.
  533. (2006). Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves.
  534. (2005). Ring A
  535. (2002). Role for P2X receptors in long-term potentiation.
  536. (2004). Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue.
  537. (2005). Role of glial cells in cerebral ischemia.
  538. (2006). Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death.
  539. (2004). Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress.
  540. (2007). Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.
  541. (2003). Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo.
  542. Ruan HZ (2008a) P2Y1 receptor-mediated glutamate release from cultured dorsal spinal cord astrocytes.
  543. Ruan HZ (2008b) Inhibition of ATP-induced glutamate release by MRS2179 in cultured dorsal spinal cord astrocytes.
  544. Sabirov RZ (2006b) Roles of two types of anion channels in glutamate release from mouse astrocytes under ischemic or osmotic stress.
  545. (1993). Schousboe A
  546. (1996). Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia.
  547. (1996). Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons.
  548. (1994). Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
  549. (1998). Selective glial vulnerability following transient global ischemia in rat brain.
  550. (2004). Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury.
  551. (1982). Selective neuron loss after cerebral ischemia in the rat: possible role of transmitter glutamate.
  552. (2009). Selective P2X(7) receptor antagonists for chronic inflammation and pain.
  553. (1990). Selective vulnerability of cultured cortical glia to injury by extracellular acidosis.
  554. (2003). Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices.
  555. (1998). Sensory presynaptic and widespread somatodendritic immunolocalization of central ionotropic P2X ATP receptors.
  556. (1996). Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats.
  557. (1970). Smythe A
  558. (2002). Spatial and temporal aspects of Ca2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes.
  559. (2008). Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter.
  560. Spyer KM (2005a) Release of ATP in the ventral medulla during hypoxia in rats: role in hypoxic ventilatory response.
  561. Spyer KM (2005b) ATP is a mediator of chemosensory transduction in the central nervous system.
  562. (2002). Stimulation of Ca(2+) influx through ATP receptors on rat brain synaptosomes: identification of functional P2X(7) receptor subtypes.
  563. (2004). Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons.
  564. (1998). Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity.
  565. (2003). Storage and release of ATP from astrocytes in culture.
  566. (2000). Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor.
  567. (2005). Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia.
  568. (2002). Suramin reduces infarct volume in a model of focal brain ischemia in rats.
  569. (1988). Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.
  570. (1999). Surprenant A
  571. Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor.
  572. (2002). Sustained Ca2+-induced Ca2+-release underlies the post-glutamate lethal Ca2+ plateau in older cultured hippocampal neurons.
  573. (2006). Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro.
  574. (1990). Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures.
  575. (1994). Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP.
  576. (1998). Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice.
  577. (2006). Target cell-specific modulation of neuronal activity by astrocytes.
  578. Tator CH (1993a) Secondary Ca2+ overload indicates early neuronal injury which precedes staining with viability indicators.
  579. (2007). Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus.
  580. (1982). Temporal profile of neuronal damage in a model of transient forebrain ischemia.
  581. (2008). Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter.
  582. (1998). The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress.
  583. (1986). The anticonvulsant MK801 is a potent N-methyl-D-aspartate antagonist.
  584. (2008). The cost of cerebral ischaemia.
  585. (2005). The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
  586. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
  587. (1995). The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.
  588. (2005). The excitoprotective effect of Nmethyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons.
  589. (1991). The excitotoxin hypothesis in relation to cerebral ischemia.
  590. (2006). The glutamate story.
  591. (1997). The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes.
  592. (2008). The mechanisms of acute ischemic injury in the cell processes of developing white matter astrocytes.
  593. (1998). The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils.
  594. (2001). The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocytes during oxygen-glucose deprivation.
  595. (2008). The P2X7 receptor channel pore dilates under physiological ion conditions.
  596. (2009). The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore.
  597. (2006). The P2X7 receptor: a key player in IL-1 processing and release.
  598. (1997). The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
  599. (2007). The role of ATP and adenosine in the brain under normoxic and ischemic conditions.
  600. (1990). The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.
  601. (2007). The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
  602. (2005). The role of neurogenic astroglial cells in the developing and adult central nervous system. In: Neuroglia, 2nd edition Edition (Kettenmann
  603. (2006). The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kisbenzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
  604. (1957). The toxic effect of sodium L-glutamate on the inner layers of the retina.
  605. (1997). Tissue distribution of the P2X7 receptor.
  606. (1995). Toxic NMDA-receptor activation occurs during recovery in a tissue culture model of ischemia.
  607. (1997). Transmitter-induced calcium responses differ in astrocytes acutely isolated from rat brain and in culture.
  608. (2000). Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate.
  609. (1999). Traynelis SF
  610. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.
  611. (2005). TRPMs and neuronal cell death.
  612. (1983). Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics.
  613. (2003). Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists.
  614. (2008). Up-regulation of P2X7 receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons.
  615. (1990). Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes.
  616. (1995). Use of BCECF and propidium iodide to assess membrane integrity of acutely isolated CA1 neurons from rat hippocampus.
  617. (2006). Verkhratsky A
  618. Verkhratsky A (2003) P2X receptor-mediated excitatory synaptic currents in somatosensory cortex.
  619. Verkhratsky A (2008) P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes.
  620. (2007). Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes.
  621. (2006). Vesicular release of ATP at central synapses.
  622. (2006). Vesicular transmitter release from astrocytes.
  623. (1996). Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation.
  624. Volonte C (2001a) Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue.
  625. Volonte C (2001b) Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists.
  626. Volonte C (2004a) Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures.
  627. Volonte C (2004b) Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor.
  628. (2007). Volterra A
  629. (2004). Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra.
  630. (1997). von Kugelgen I
  631. (1996). Vulnerability of CA1 neurons to glutamate is developmentally regulated.
  632. (1997). Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes.
  633. (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
  634. (2002). Zdebik AA

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.